Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May 24:9:39-46.
doi: 10.4137/SART.S22233. eCollection 2015.

Emergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine: Results from the Drug Abuse Warning Network (DAWN)

Affiliations

Emergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine: Results from the Drug Abuse Warning Network (DAWN)

Margaret E Mattson et al. Subst Abuse. .

Abstract

Case reports in medical literature suggest that the atypical antipsychotic quetiapine, a medication not previously considered to have abuse potential, is now being subject to misuse and abuse (MUA; ie, taken when not prescribed for them or used in a way other than instructed by their health professional). Here we present systematic, nationally representative data from the 2005 to 2011 Drug Abuse Warning Network (DAWN) for prevalence of emergency department (ED) visits among the U.S. general population involving quetiapine and related to MUA, suicide attempts, and adverse reactions. Nationally, quetiapine-related ED visits increased 90% between 2005 and 2011, from 35,581 ED visits to 67,497. DAWN data indicate that when used without medical supervision for recreational/self-medication purposes, quetiapine poses health risks for its users, especially among polydrug users and women. These findings suggest that the medical and public health communities should increase vigilance concerning this drug and its potential for MUA.

Keywords: Drug Abuse Warning Network; emergency department visits; misuse and abuse; quetiapine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trends in ED visits involving quetiapine for MUA, suicide attempts, and adverse reactions: 2005–2011. Notes: *Comparing 2005 to 2011, visits are higher in 2011 for total visits at the P < 0.001 level, for suicide attempt visits at the P = 0.03 level, and for adverse reaction visits at the P < 0.001 level.

Similar articles

Cited by

References

    1. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Saf. 2011;20(2):177–84. - PMC - PubMed
    1. McDonagh MS, Peterson K, Carson S, Fu R, Thakurta S. Drug Class Review: Atypical Antipsychotic Drugs. Update 3. Portland, Oregon: Center for Evidence-based Policy, Oregon Health & Science University; 2008. Available at: http://www.ncbi.nlm.nih.gov/books/NBK50583/pdf/TOC.pdf.
    1. Rowe DL. Off-label prescription of quetiapine in psychiatric disorders. Expert Rev Neurother. 2007;7(7):841–52. - PubMed
    1. Maher AR, Theodore G. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. J Manag Care Pharm. 2012;18(5 suppl B):S1–20. - PMC - PubMed
    1. Decision Resources. Treatment Algorithms in Bipolar Disorder. 2015. [Accessed March 12, 2015]. Available at: http://decisionresources.com/Products-and-Services/Report?r=algocg0114.

LinkOut - more resources